2018 News Releases

Study finds elevated risk of certain rare blood cancers after chemotherapy for most solid tumors

• December 20, 2018

Ibrutinib plus rituximab superior to standard treatment for some patients with chronic leukemia

• December 4, 2018

Statement from NCI Director Dr. Norman E. Sharpless on the Death of Senator John McCain

• August 27, 2018

NCI-led research team develops predictor for immunotherapy response in melanoma

• August 20, 2018

Rosenberg, NCI-supported researchers to receive 2018 Albany Prize

• August 15, 2018

Cetuximab with radiation found to be inferior to standard treatment in HPV-positive oropharyngeal cancer

• August 14, 2018

NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men

• July 17, 2018

NCI and VA collaborate to boost veterans’ access to cancer clinical trials

• July 10, 2018

New approach to immunotherapy leads to complete response in breast cancer patient unresponsive to other treatments

• June 4, 2018

NCI-MATCH precision medicine clinical trial releases new findings, strengthens path forward for targeted cancer therapies

• June 4, 2018

TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

• June 3, 2018

NCI study finds gut microbiome can control antitumor immune function in liver

• May 24, 2018

Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized

• May 22, 2018

NCI study revises molecular classification for most common type of lymphoma

• April 11, 2018

NIH completes in-depth genomic analysis of 33 cancer types

• April 5, 2018

NIH-funded study shows sorafenib improves progression-free survival for patients with rare sarcomas

• March 28, 2018

Szent-Györgyi Prize to honor NCI’s Douglas R. Lowy and John T. Schiller

• February 15, 2018